Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series B leads to €16mm for Okairos AG

Executive Summary

Italian firm Okairos AG (infectious disease vaccines) raised €16mm ($20.5mm) in its Series B financing round led by first-time backer Versant Ventures, which was joined by fellow new investor Boehringer Ingelheim Venture Fund and returning shareholders BioMedPartners and Novartis Venture Funds. The company's 2007 Series A generated €7.2mm.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies